The first one thousand liver transplants in Turin: A single-center experience in Italy

Transplant International

Volumn 18, Issue 12, 2005, Pages 1328-1335

  Salizzoni, Mauro ^a   Cerutti, Elisabetta ^a   Romagnoli, Renato ^a   Lupo, Francesco ^a   Franchello, Alessandro ^a   Zamboni, Fausto ^a   Gennari, Fabrizio ^a   Strignano, Paolo ^a   Ricchiuti, Alessandro ^a   Brunati, Andrea ^a   Schellino, Maria Maddalena ^a   Ottobrelli, Antonio ^a   Marzano, Alfredo ^a   Lavezzo, Bruna ^a   David, Ezio ^a   Rizzetto, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Cyclosporine A; Liver transplantation; Marginal graft; Operating room extubation; Piggy back technique; Viral cirrhosis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HEPATITIS B SURFACE ANTIBODY; INTERFERON; LAMIVUDINE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD3; RIBAVIRIN; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; EXTUBATION; FALSE ANEURYSM; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; IRON OVERLOAD; ISCHEMIA; ITALY; LENGTH OF STAY; LEUKOPENIA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER HEMORRHAGE; LIVER VEIN THROMBOSIS; MAJOR CLINICAL STUDY; NEUROTOXICITY; OPERATION DURATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; STENOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FIBROSIS; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; ITALY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; MODELS, STATISTICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 28444494400     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00215.x     Document Type: Article

References (32)

1. Starzl TE, Demetris AJ. Liver Transplantation Year Book. Chicago, IL: Medical Publishers, 1994.
2. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989; 210: 649.
3. Lavezzo B, Franchello A, Smedile A, et al. Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin. J Hepatol 2002; 37: 247.
4. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696.
5. Marzano A, Gaia S, Ciardo V, et al. Prophylaxis of hepatitis B virus infection before liver transplantation, 1990-2001: a single-center experience. Transplant Proc 2003; 35: 1020.
6. Adam R, Cailliez V, Majno P, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000; 356: 621.
7. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232: 490.
8. Lerut JP, Molle G, Donataccio M, et al. Cavocaval liver transplantation without venovenous bypass and without temporary portocaval shunting: the ideal technique for adult liver grafting? Transpl Int 1997; 10: 171.
9. Salizzoni M, Andorno E, Bossuto E, et al. Piggy-back techniques versus classical technique in orthotopic liver transplantation: a review of 75 cases. Transplant Proc 1994; 26: 3552.
10. Strasberg SM, Howard TK, Molmenti EP, Herd M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829.
11. Platz KP, Mueller AR, Schafer C, et al. Influence of warm ischemia time on initial graft function in human liver transplantation. Transplant Proc 1997; 29: 3458.
12. Schon MR, Kollmar O, Akkoc N, et al. Cold ischemia affects sinusoidal endothelial cells while warm ischemia affects hepatocytes in liver transplantation. Transplant Proc 1998; 30: 2318.
13. Settmacher U, Nussler NC, Glanemann M, et al. Venous complications after orthotopic liver transplantation. Clin Transplant 2000; 14: 235.
14. Stange BJ, Glanemann M, Nuessler NC, Settmacher U, Steinmuller T, Neuhaus P. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl 2003; 9: 612.
15. Tung BY, Kimmey MB. Biliary complications of orthotopic liver transplantation. Dig Dis 1999; 17: 133.
16. Mandell MS, Lezotte D, Kam I, Zamudio S. Reduced use of intensive care after liver transplantation: patient attributes that determine early transfer to surgical wards. Liver Transpl 2002; 8: 682.
17. Glanemann M, Langrehr J, Kaisers U, et al. Postoperative tracheal extubation after orthotopic liver transplantation. Acta Anaesthesiol Scand 2001; 45: 333.
18. Salizzoni M, Franchello A, Zamboni F, et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 2003; 16: 486.
19. Busuttil RW, Shaked A, Millis JM, et al. One thousand liver transplants. The lessons learned. Ann Surg 1994; 219: 490.
20. Markmann JF, Markowitz JS, Yersiz H, et al. Long-term survival after retransplantation of the liver. Ann Surg 1997; 226: 408.
21. Doyle HR, Morelli F, McMichael J, et al. Hepatic retransplantation - an analysis of risk factors associated with outcome. Transplantation 1996; 61: 1499.
22. Saab S, Wang V. Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options. J Clin Gastroenterol 2003; 37: 155.
23. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
24. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202.
25. Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003; 38: 1282.
26. Nakagawa M, Sakamoto N, Enomoto N, et al. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem Biophys Res Commun 2004; 313: 42.
27. Inoue K, Sekiyama K, Yamada M, Watanabe T, Yasuda H, Yoshiba M. Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. J Gastroenterol 2003; 38: 567.
28. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673.
29. Marzano A, Gaia S, Ghisetti V, et al. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl 2005; 11: 402.
30. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
31. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235: 533.
32. Salizzoni M, Romagnoli R, Lupo F, et al. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation. Transplantation 2003; 76: 844.